James Mackaness Insider Profile
11 Followers
James Mackaness, CFO and COO at Iridex, holds 131.76K shares in Soleno Therapeutics (Ticker: SLNO), holds 0.00 shares in Invuity (Ticker: IVTY), holds 45.05K shares in Iridex (Ticker: IRIX).
Profitable Transactions
3 out of 18 Profitable Transactions
Average Return
-45.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by James Mackaness
James Mackaness's Trading History
Iridex
Aug 21, 2015
CFO and COO
Informative Sell
16.97K
$44.60K
Soleno Therapeutics
Jan 23, 2026
CFO
Uninformative Buy
―
$3.96M
Invuity
Oct 23, 2018
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see James Mackaness's performance on stock
You May Also Like
James Mackaness insider profile FAQ
What is the percentage of profitable transactions made by James Mackaness?
The percentage of profitable transactions made by James Mackaness is 17%.
What is the average return per transaction made by James Mackaness?
The average return per transaction made by James Mackaness is -45.20%.
What stocks does James Mackaness hold?
James Mackaness holds: IRIX, SLNO, IVTY stocks.
What was James Mackaness’s latest transaction?
James Mackaness latest transaction was an Uninformative Buy of ―.
What was James Mackaness's most profitable transaction?
James Mackaness’s most profitable transaction was an Informative Sell of SLNO stock on March 31, 2025. The return on the trade was 52.70%.
What is James Mackaness's role in Iridex?
James Mackaness's role in Iridex is CFO and COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.